CIK 0001680367
- Non-accelerated filer
- Smaller reporting company
Shattuck Labs, Inc.
Sign in to watch- Ticker
- STTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812575858
- Phone
- +1 512-900-4690
- Business address
- 500 W. 5TH STREET, AUSTIN, TX, 78701
- Former names
- Shattuck Labs, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-10 | Pandite Arundathy N. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +69,475 | 69,475 | ||
| 2022-01-10 | Neill Andrew R Chief Financial Officer | Grant or award | +33,325 | 109,491 | ||
| 2022-01-10 | Neill Andrew R Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +66,650 | 66,650 | ||
| 2022-01-10 | Thomson Erin Ator General Counsel | Grant or award | +22,825 | 69,084 | ||
| 2022-01-10 | Thomson Erin Ator General Counsel | Grant or award · Stock Option (Right to Buy) | +45,650 | 45,650 | ||
| 2022-01-10 | Schreiber Taylor Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +178,150 | 178,150 | ||
| 2021-11-12 | Brownstein Carrie Director | Grant or award · Stock Option (Right to Buy) | +10,467 | 10,467 | ||
| 2021-11-11 | Neill Andrew R Chief Financial Officer | Option exercise | +20,000 | $2.95 | $59K | 76,166 |
| 2021-11-11 | Neill Andrew R Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −20,000 | 43,705 | ||
| 2021-11-10 | Schreiber Taylor Chief Executive Officer | Option exercise | +3,926 | $4.67 | $18K | 13,126 |
| 2021-11-10 | Schreiber Taylor Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −3,926 | 180,523 | ||
| 2021-10-19 | Thomson Erin Ator General Counsel | Sale | −33,000 | $19.50 | $644K | 46,259 |
| 2021-08-10 | Neill Andrew R Chief Financial Officer | Option exercise | +2,203 | $0.01 | $22 | 56,166 |
| 2021-08-10 | Neill Andrew R Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −2,203 | 0 | ||
| 2021-08-10 | Pandite Arundathy N. Chief Medical Officer | Option exercise | +4,259 | $0.01 | $43 | 106,166 |
| 2021-08-10 | Pandite Arundathy N. Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −4,259 | 0 | ||
| 2021-08-10 | Schreiber Taylor Chief Executive Officer | Option exercise | +3,926 | $4.67 | $18K | 9,200 |
| 2021-08-10 | Schreiber Taylor Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −3,926 | 184,449 | ||
| 2021-07-15 | Neill Andrew R Chief Financial Officer | Sale | −2,000 | $22.13 | $44K | 53,963 |
| 2021-07-15 | Thomson Erin Ator General Counsel | Sale | −2,000 | $22.18 | $44K | 79,259 |
Page 11 of 18 · 360 trades